Back To TopGet Opthea Updates
Anand Sundaram

Anand Sundaram

Anand Sundaram brings more than a decade of commercial experience in brand strategy, marketing, access and reimbursement, digital, and sales across retina, cardiovascular, and infectious disease to Opthea. Mr. Sundaram joins the company from Astellas (formerly Iveric...
Kevin Bitter

Kevin Bitter

Mr. Bitter brings broad experience in strategic planning and corporate development for life sciences companies, including two completed M&A transactions. Most recently, he led business development at Graybug Vision to in‐license several development programs for...
Anthony Bonifazio

Anthony Bonifazio

Anthony Bonifazio brings more then 25 years of commercial experience in market access, advocacy, reimbursement, and sales across retina, cardiovascular and oncology.  Mr. Bonifazio joins Opthea from Astellas (former IVERIC BIO) where he served as Vice President,...
John Han

John Han

Dr. Han’s career in biotechnology and pharmaceutical industry spans over 25 years, with 19 years in ophthalmology. He brings experience in early and late‐stage drug development in both anterior and posterior ophthalmology. He has a proven track record of success in...